glp-1 agonists oral Peptidyl and Non-Peptidyl Glucagon-Like Peptide-1 Receptor π¨ A Pill for Obesity?
Description
Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Clinical application of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus
However, phase 2 trials are not powered to detect rare cardiovascular events
Indications for sitagliptin include use in type 2 diabetes as monotherapy or in combination with metformin or thiazolidinediones
An agonist is a natural ligand or a substance mimics the action of natural ligands that initiates responses when it binds to a specific receptor
